CWIR yields 20000000.00% · PFE yields 6.13%● Live data
📍 CWIR pulled ahead of the other in Year 1
Combined, CWIR + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWIR + PFE for your $10,000?
Central Wireless, Inc., a development stage company, operates as a wireless communications infrastructure company. It primarily engages in the design, engineering, development, and construction of towers for the transmission of broadband, cellular, and other wireless communications signals. These towers include the monopole, the guy tower, stealth tower designs, and self-support towers, and broadcast telecommunications signals for personal communications services, cellular, wireless data, paging, and broadcast technologies. The company also provides related services, including site acquisition, zoning, and antennae and line installation. It also offers various consulting services, including lease negotiation and assistance in regulatory matters. The company's customers primarily include broadband and other wireless telecommunications carriers, and individuals or businesses that desire to lease or own telecommunications towers. It principally operates in the greater Sarasota, Florida region; Oklahoma; and Minnesota in the United States. Central Wireless, Inc. is based in Las Vegas, Nevada.
Full CWIR Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.